CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Head & Neck Cancers
Immunotherapy in GU Cancers
Immunotherapy in Lung Cancer
Immunotherapy in Melanoma
Mantle Cell Lymphoma
Melanoma & Skin Cancer
Oncology Nursing News
Precision Medicine in Oncology
Special Reports in Personalized Cancer Care
SELECT A TOPIC
Attend An Event
State of the Science Summit
Regional Seminar Series
OS by PS in Metastatic Pancreatic Cancer Treatment- Data From an Exploratory Subgroup Analysis
<< View More Conferences
2018 State of the Science Summit on Breast Cancer
Oncology Conference Multimedia
View more videos >>
Dr. Novik on CDK4/6 Inhibitor Combinations in Breast Cancer
Dr. Adams on Combinatorial Approaches in Triple-Negative Breast Cancer
Dr. Gerber on the Future Landscape of Radiation Oncology
Oncology Conference Articles
Immunotherapy Remains Focal Point in TNBC
Sylvia Adams, MD, discusses the path forward for immunotherapy in triple-negative breast cancer.
Expert Sees Biosimilars as Integral to Expanding Access, Controlling Costs in Oncology
Yelena Novik, MD, shares her thoughts on the use of biosimilars in oncology and their potential impact on practice.
CDK4/6 Inhibitors Continue to Revolutionize ER+ Breast Cancer Care
Yelena Novik, MD, discusses the application of CDK4/6 inhibition and methods to overcome resistance in ER-positive breast cancer.
Optimal Duration of Adjuvant Endocrine Therapy Undecided in ER+ Breast Cancer
Maryann J. Kwa, MD, discusses the optimal duration of endocrine therapy in the treatment of patients with early-stage ER-positive breast cancer.
Esteva Recaps Advances in HER2-Targeted Therapy in Breast Cancer
Francisco J. Esteva, MD, PhD, discusses recent advances and clinical findings with HER2-targeted therapies across the neoadjuvant, adjuvant, and metastatic settings.
FDA Approvals in Pediatric ALL and PNH, Japanese Approves Pembrolizumab in 5 Indications, and More
Treatment Goals in Refractory mCRC
FDA Issues Letter Regarding Safety Concerns With Paclitaxel-Coated Devices
FDA Grants Zanubrutinib Breakthrough Designation for Mantle Cell Lymphoma
Controversy Adds Caution to CRISPR Editing in United States
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
American Journal of Managed Care
Oncology Nursing News
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
Terms & Conditions
2 Clarke Drive
Cranbury, NJ 08512
Copyright OncLive 2006-2018
Intellisphere, LLC. All Rights Reserved.